Related references
Note: Only part of the references are listed.Pathogenesis of psoriasis and development of treatment
Eisaku Ogawa et al.
JOURNAL OF DERMATOLOGY (2018)
NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways
Yuchen Zhuang et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2018)
Calcipotriol inhibits proliferation of human keratinocytes by downregulating STAT1 and STAT3 signaling
Wenli Liang et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2017)
RAC1 activation drives pathologic interactions between the epidermis and immune cells
Marten C. C. Winge et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ
Claus Johansen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS
Jinjing Jia et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways
Huiling Jing et al.
MOLECULAR MEDICINE REPORTS (2016)
The Risk of Cancer in Patients With Psoriasis A Population-Based Cohort Study in the Health Improvement Network
Zelma C. Chiesa Fuxench et al.
JAMA DERMATOLOGY (2016)
The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma
Kyohei Yoshikawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells
Katherine A. Hollywood et al.
MOLECULAR BIOSYSTEMS (2015)
Red Light Combined with Blue Light Irradiation Regulates Proliferation and Apoptosis in Skin Keratinocytes in Combination with Low Concentrations of Curcumin
Tianhui Niu et al.
PLOS ONE (2015)
Etiology and Pathogenesis of Psoriasis
Wolf-Henning Boehncke
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
Complex Role of TNF Variants in Psoriatic Arthritis and Treatment Response to Anti-TNF Therapy: Evidence and Concepts
Ulrike Hueffmeier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
Flore Nallet-Staub et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Amphiregulin
Carmen Berasain et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition
Claude Gerard et al.
INTERFACE FOCUS (2014)
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes
Erica Lorenzetto et al.
ONCOTARGET (2014)
CXCR4 Negatively Regulates Keratinocyte Proliferation in IL-23-Mediated Psoriasiform Dermatitis
Tomonori Takekoshi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
1α,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT/mTOR Signaling Cascades: A Therapeutic Agent for Psoriasis
Ananya Datta Mitra et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
RASSF1A-Mediated Regulation of AREG via the Hippo Pathway in Hepatocellular Carcinoma
Ei Yong Ahn et al.
MOLECULAR CANCER RESEARCH (2013)
Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma
Xinying Huo et al.
ONCOLOGY REPORTS (2013)
The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis
Tao Shen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis
Lauren Young et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2012)
Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
Caroline H. Diep et al.
PLOS ONE (2012)
The Hippo Pathway in Biological Control and Cancer Development
Siew Wee Chan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Bin Zhao et al.
NATURE CELL BIOLOGY (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Genome-Wide Interrogation Identifies YAP1 Variants Associated with Survival of Small-Cell Lung Cancer Patients
Chen Wu et al.
CANCER RESEARCH (2010)
Overexpression of YAP1 induces immortalization of normal human keratinocytes by blocking clonal evolution
Irene D'Addario et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
Jianmin Zhang et al.
NATURE CELL BIOLOGY (2009)
The emerging role of the Hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
Qi Zeng et al.
CANCER CELL (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Celine Pinheiro et al.
VIRCHOWS ARCHIV (2008)
Amphiregulin overexpression results in rapidly growing keratinocytic tumors - An in vivo xenograft model of Keratoacanthoma
SD Billings et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Share Paper
